⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Comanche Biopharma Corp. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Comanche Biopharma Corp.
↗Concord, USA
Comanche Biopharma is a clinical-stage biopharmaceutical company dedicated to improving maternal and fetal health by developing the first therapy targeting a root cause of preeclampsia. The company focuses on RNA interference (siRNA) therapeutics to silence genes involved in the overproduction of sFlt1, a protein linked to the vascular damage and complications associated with preterm preeclampsia.
Founded in 2020, the company is backed by prominent venture capital firms and is committed to making its therapies globally accessible. Comanche Biopharma is currently advancing its lead candidate, CBP-4888, through clinical development, aiming to provide a definitive treatment for a condition that currently has no cure other than premature delivery.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Maternal and Fetal Medicine / RNA Therapeutics
SIZE & FINANCIALS
Employees:1-50
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$75M
Investors:New Enterprise Associates (NEA), Atlas Venture, GV (Google Ventures), F-Prime Capital, Lilly Asia Ventures (LAV), Longview Healthcare Ventures
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1
Modalities:RNA interference (siRNA)
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Emerging
Competitors:Evergreen Therapeutics, Gmax Biopharm, Corion Biotech
LEADERSHIP
Key Executives:
Scott Johnson, M.D. - CEO and Co-Founder
Mike Young - President and Co-Founder
Richard Colvin, M.D., Ph.D. - Global Head of R&D
Allison August, M.D. - Chief Medical Officer
Board Members:Scott Gottlieb, M.D., David Grayzel, M.D., John McHutchison, AO, MD, Ann Taylor, M.D.
LINKS
Website:comanchebiopharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Comanche Biopharma Corp.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.